Skip to main content

Advertisement

Log in

Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-β1 in patients with chronic renal failure

  • ORIGINAL ARTICLE
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Background

We previously reported a significant increase in plasma TGF-β1 in patients with chronic renal failure (CRF). Progression of CRF may be caused by persistent renal production of TGF-β1. In CRF rat models, an oral carbonic absorbent (AST-120) reduces the expression of the TGF-β1 gene in the kidney, and delays the progression of CRF, in part by alleviating the overload of indoxyl sulfate. The aim of this study was to evaluate the effect of AST-120 on plasma levels of indoxyl sulfate and TGF-β1 in CRF patients.

Methods

Ten CRF patients (aged 59.3 ± 9.5 years, 5 men, serum creatinine 4.37 ± 1.72 mg/dl) were enrolled in this study. All patients maintained a regular dietary therapy and the same medication throughout the study. AST-120 was added at a dose of 6 g/day. Parameters including the slope of the reciprocal of the serum creatinine – time plot, plasma indoxyl sulfate level, and plasma and urinary levels of TGF-β1 were compared before and after the treatment with AST-120. The mean observation periods before and after the treatment were 9.7 ± 2.8 and 6.5 ± 2.9 months, respectively.

Results

Administration of AST-120 significantly reduced the plasma levels of indoxyl sulfate (1.42 ± 1.50 vs. 1.26 ± 1.40 mg/dl, P < 0.05) and TGF-β1 (17.9 ± 7.2 vs. 10.6 ± 4.7 ng/ml, P < 0.05) and improved the slope of the reciprocal of serum creatinine (−0.061 ± 0.041 vs. −0.032 ± 0.055 dl/mg/year, P < 0.05).

Conclusions

These results support the notion that indoxyl sulfate and TGF-β1 may be involved in the progression of CRF, and that the oral adsorbent AST-120 may suppress the progression, at least in part, by reducing overproduction of TGF-β1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. T Niwa T Nomura S Sugiyama T Miyazaki S Tsukushi S Tsutsui (1997) ArticleTitleThe protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients Kidney Int 62 S23–8 Occurrence Handle1:CAS:528:DyaK2sXnt1Oktb4%3D

    CAS  Google Scholar 

  2. T Sanaka K Fujimoto J Niwayama T Naito C Higuchi T Akizawa et al. (2003) ArticleTitleEffect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF Am J Kidney Dis 4 S35–7

    Google Scholar 

  3. Y Tsubakihara Y Takabatake K Oka T Shoji N Okada I Takahito et al. (2003) ArticleTitleEffects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients Am J Kidney Dis 41 S38–41 Occurrence Handle12612950 Occurrence Handle10.1053/ajkd.2003.50015 Occurrence Handle1:CAS:528:DC%2BD3sXisFamt7s%3D

    Article  PubMed  CAS  Google Scholar 

  4. N Yorioka T Ito T Masaki S Ogata Y Asakimori C Tanji et al. (2002) ArticleTitleDose-dependent effect of an oral adsorbent, AST-120, in patients with early chronic renal failure J Int Med Res 30 467–75 Occurrence Handle12449515 Occurrence Handle1:CAS:528:DC%2BD38XpsVWnurg%3D

    PubMed  CAS  Google Scholar 

  5. T Miyazaki I Aoyama M Ise H Seo T Niwa (2000) ArticleTitleAn oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys Nephrol Dial Transplant 15 1773–81 Occurrence Handle11071964 Occurrence Handle10.1093/ndt/15.11.1773 Occurrence Handle1:CAS:528:DC%2BD3cXos1Ogs7w%3D

    Article  PubMed  CAS  Google Scholar 

  6. WA Border E Ruoslahit (1992) ArticleTitleTransforming growth factor-β1 in disease: the dark side of tissue repair J Clin Invest 90 1–7 Occurrence Handle1634602 Occurrence Handle1:CAS:528:DyaK38XltV2ju7s%3D Occurrence Handle10.1172/JCI115821

    Article  PubMed  CAS  Google Scholar 

  7. WA Border S Okuda LR Languino E Ruoslahti (1990) ArticleTitleTransforming growth factor-β1 regulates production of proteoglycans by mesangial cells Kidney Int 37 689–95 Occurrence Handle2407884 Occurrence Handle1:CAS:528:DyaK3cXhvFKiur4%3D

    PubMed  CAS  Google Scholar 

  8. S Okuda LR Languino E Ruoslahti WA Border (1990) ArticleTitleElevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix J Clin Invest 86 453–62 Occurrence Handle2200803 Occurrence Handle1:CAS:528:DyaK3cXltlSnsLs%3D

    PubMed  CAS  Google Scholar 

  9. K Tamaki S Okuda T Ando T Iwamoto M Nakayama M Fujishima (1994) ArticleTitleTGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy Kidney Int 45 525–36 Occurrence Handle8164441 Occurrence Handle1:CAS:528:DyaK2cXjt1Slu70%3D

    PubMed  CAS  Google Scholar 

  10. K Tamaki S Okuda M Nakayama T Yanagida M Fujishima (1996) ArticleTitleTransforming growth factor-β1 in hypertensive renal injury in Dahl salt-sensitive rats J Am Soc Nephrol 7 2578–89 Occurrence Handle8989736 Occurrence Handle1:CAS:528:DyaK2sXnsFWgsA%3D%3D

    PubMed  CAS  Google Scholar 

  11. M Fujisawa R Haramaki H Miyazaki T Imaizumi S Okuda (2000) ArticleTitleRole of lipoprotein (a) and TGF-β in atherosclerosis of hemodialysis patients J Am Soc Nephrol 11 1889–95 Occurrence Handle11004220 Occurrence Handle1:CAS:528:DC%2BD3cXnsVCrsr0%3D

    PubMed  CAS  Google Scholar 

  12. R Haramaki K Tamaki M Fujisawa H Ikedo N Haramaki S Okuda (2001) ArticleTitleSteroid therapy and urinary transforming growth factor-β1 in IgA nephropathy Am J Kidney Dis 38 1191–8 Occurrence Handle11728950 Occurrence Handle1:CAS:528:DC%2BD38XisFCktw%3D%3D

    PubMed  CAS  Google Scholar 

  13. T Niwa M Ise (1994) ArticleTitleIndoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis J Lab Clin Med 124 96–104 Occurrence Handle8035108 Occurrence Handle1:CAS:528:DyaK2cXlslKrs7k%3D

    PubMed  CAS  Google Scholar 

  14. T Miyazaki M Ise H Seo T Niwa (1997) ArticleTitleIndoxyl sulfate increases the gene expressions of TGF-β1, TIMP-1 and pro-a(I) collagen in uremic rat kidneys Kidney Int 52 S12–S22

    Google Scholar 

  15. T Miyazaki M Ise M Hirata K Endo Y Ito H Seo et al. (1997) ArticleTitleIndoxyl sulfate stimulates renal synthesis of TGF-β1 and progression in renal failure Kidney Int 52 S211–14

    Google Scholar 

  16. T Niwa T Miyazaki N Hashimoto H Hayashi M Ise Y Uehara et al. (1992) ArticleTitleSuppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats Am J Nephrol 12 201–6 Occurrence Handle1481866 Occurrence Handle1:STN:280:DyaK3s7ivVemsg%3D%3D

    PubMed  CAS  Google Scholar 

  17. H Kanai H Mitsuhashi K Ono S Yano T Naruse (1994) ArticleTitleIncreased excretion of urinary transforming growth factor-β in patients with focal glomerular sclerosis Nephron 66 391–5 Occurrence Handle8015640 Occurrence Handle1:STN:280:DyaK2c3os1SntA%3D%3D

    PubMed  CAS  Google Scholar 

  18. E Honkanen AM Teppo T Tornoth PH Groop C Gronhagen-Riska (1997) ArticleTitleUrinary transforming growth factor-β in membranous glomerulonephritis Nephrol Dial Transplant 12 2562–8 Occurrence Handle9430852 Occurrence Handle10.1093/ndt/12.12.2562 Occurrence Handle1:STN:280:DyaK1c%2Fpt1OhsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  19. K Sharma FN Ziyadeh B Alzahabi TA Mc Gowan S Kapoor BR Kurnik et al. (1997) ArticleTitleIncreased renal production of transforming growth factor-β1 in patients with type II diabetes Diabetes 46 854–9 Occurrence Handle9133555 Occurrence Handle1:CAS:528:DyaK2sXjtVGntbw%3D

    PubMed  CAS  Google Scholar 

  20. P Inigo JM Campitol S Lario C Piera B Campos B Bescos et al. (2001) ArticleTitleEffects of losartan and amlodipine on intrarenal hemodynamics and TFG-β1 plasma levels in a crossover trial in renal transplant recipients J Am Soc Nephrol 12 822–7 Occurrence Handle11274244 Occurrence Handle1:CAS:528:DC%2BD3MXjtVWgt7o%3D

    PubMed  CAS  Google Scholar 

  21. JM Campistol P Inigo W Jimenez S Lario PH Clesca F Oppenheimer et al. (1999) ArticleTitleLosartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy Kidney Int 56 714–9 Occurrence Handle10432413 Occurrence Handle10.1046/j.1523-1755.1999.00597.x Occurrence Handle1:CAS:528:DyaK1MXltlOgs7s%3D

    Article  PubMed  CAS  Google Scholar 

  22. JB Kopp VM Factor M Mozes P Nagy N Sanderson EP Bottinger et al. (1996) ArticleTitleTransgenic mice with increased plasma levels of TGF-beta-1 develop progressive renal disease Lab Invest 74 991–1003 Occurrence Handle8667617 Occurrence Handle1:CAS:528:DyaK28Xkt1Knsb0%3D

    PubMed  CAS  Google Scholar 

  23. JS Cameron (1990) ArticleTitleProteinuria and progression in human glomerular disease Am J Nephrol 10 S81–7 Occurrence Handle10.1159/000168199

    Article  Google Scholar 

  24. S Okuda (1999) ArticleTitleProcess of tubulointerstitial injury in progressive renal diseases Clin Exp Nephrol 3 65–74 Occurrence Handle10.1007/s101570050013 Occurrence Handle1:CAS:528:DyaK1MXls1ensLk%3D

    Article  CAS  Google Scholar 

  25. K Horike T Usami Y Kamiya T Kamiya A Yoshida S Itoh et al. (2003) ArticleTitleOral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma rennin–angiotensin system or protein intake Clin Exp Nephrol 7 120–4 Occurrence Handle14586730 Occurrence Handle10.1007/s10157-003-0222-6 Occurrence Handle1:CAS:528:DC%2BD3sXmtVGnsLk%3D

    Article  PubMed  CAS  Google Scholar 

  26. E Imai M Takenaka Y Isaka T Moriyama Y Akagi J Kakuchi et al. (2003) ArticleTitleChronic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet Clin Exp Nephrol 7 113–9 Occurrence Handle14586729 Occurrence Handle10.1007/s10157-002-0220-0 Occurrence Handle1:CAS:528:DC%2BD3sXmtVGnsLg%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyoshi Tamaki.

About this article

Cite this article

Iida, S., Kohno, K., Yoshimura, J. et al. Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-β1 in patients with chronic renal failure. Clin Exp Nephrol 10, 262–267 (2006). https://doi.org/10.1007/s10157-006-0441-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-006-0441-8

Key words

Navigation